Journal list Promote Sponsor
verified SJR 0,941 · Q1 • database Scopus / SJR & Web of Science & DOAJ indexed
Therapeutic Advances in Urology
United States · SAGE Publications Inc.
workspace_premium Q1 — Urology visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Therapeutic Advances in Urology

Therapeutic Advances in Urology is a journal indexed in SJR in Urology with an H index of 44. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1350 €. The scope of the journal is focused on urology, clinical urology, pharmacology. It has an SJR impact factor of 0,941 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,941.

ISSN: 1756-2872
Publisher: SAGE Publications Inc.
Category: Urology
Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,941 Q1
H-index 44
Acceptance rate pie_chart
34%
Source Acceptance_Rate
Time to publication hourglass_top
10 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
1.350 € Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

0,941

H-index

44

Docs (year)

39

Docs 3y

148

Total refs

1463

Cites 3y

461

Citable 3y

142

Cites/Doc 2y

3.62

Ref/Doc

37.51

Immediate OA

1350 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

An update on the use of gonadotropin-releasing hormone antagonists in prostate cancer

View more

Urodynamic studies in the evaluation of the older man with lower urinary tract symptoms: when, which ones, and what to do with the results

View more

Chemotherapy in penile cancer

View more

Changes in prostate apparent diffusion coefficient values during radiotherapy after neoadjuvant hormones

View more

Celecoxib for the prevention of nonmuscle invasive bladder cancer: results from a matched control study

View more

Bovine serum albumin-glutaraldehyde (BioGlue®) tissue adhesive versus standard renorrhaphy following renal mass enucleation: a retrospective comparison

View more

Best practice in the management of benign prostatic hyperplasia in the patients requiring anticoagulation

View more

Best practice in the diagnosis and management of urogenital tuberculosis

View more

Avanafil for the treatment of erectile dysfunction: initial data and clinical key properties

View more

Aquablation: a novel and minimally invasive surgery for benign prostate enlargement

View more

Appropriate use of antibiotics: an unmet need

View more

Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism?

View more
SHOW MORE ARTICLES

Anatomic robotic prostatectomy: current best practice

View more

A magnetic resonance imaging-based prediction model for prostate biopsy risk stratification

View more

An update on the role of testosterone replacement therapy in the management of hypogonadism

View more

Advances in the management of upper tract urothelial carcinoma: improved endoscopic management through better diagnostics

View more

Abiraterone in the management of castration-resistant prostate cancer prior to chemotherapy

View more

Abiraterone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: a systematic review of 'real-life' studies

View more

Abiraterone acetate in combination with prednisone in the treatment of metastatic hormone-sensitive prostate cancer: clinical evidence and experience

View more

A review of the efficacy and safety of mirodenafil in the management of erectile dysfunction

View more

A retrospective analysis of patients treated with intravesical BCG for high-risk nonmuscle invasive bladder cancer

View more

A report of a regional service for post-prostatectomy urinary incontinence: a model for best practice?

View more

A prospective, randomized comparative study of monopolar transurethral resection of the prostate versus photoselective vaporization of the prostate with GreenLight 120-W laser, in prostates less than 80cc

View more

A prospective, observational grouped analysis to evaluate the effect of triptorelin on lower urinary tract symptoms in patients with advanced prostate cancer

View more

FAQs